These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 25959569

  • 1. Current developments in gene therapy for amyotrophic lateral sclerosis.
    Scarrott JM, Herranz-Martín S, Alrafiah AR, Shaw PJ, Azzouz M.
    Expert Opin Biol Ther; 2015 Jul; 15(7):935-47. PubMed ID: 25959569
    [Abstract] [Full Text] [Related]

  • 2. Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.
    Nizzardo M, Simone C, Falcone M, Riboldi G, Rizzo F, Magri F, Bresolin N, Comi GP, Corti S.
    Cell Mol Life Sci; 2012 May; 69(10):1641-50. PubMed ID: 22094924
    [Abstract] [Full Text] [Related]

  • 3. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
    Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Matsushita T, Hanazono Y, Kume A, Nagatsu T, Ozawa K, Nakano I.
    J Neurosci; 2002 Aug 15; 22(16):6920-8. PubMed ID: 12177190
    [Abstract] [Full Text] [Related]

  • 4. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis.
    Vucic S, Kiernan MC.
    Curr Mol Med; 2009 Apr 15; 9(3):255-72. PubMed ID: 19355908
    [Abstract] [Full Text] [Related]

  • 5. Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.
    Wu R, Wang H, Xia X, Zhou H, Liu C, Castro M, Xu Z.
    Antioxid Redox Signal; 2009 Jul 15; 11(7):1523-34. PubMed ID: 19344276
    [Abstract] [Full Text] [Related]

  • 6. RNA interference and amyotrophic lateral sclerosis.
    Rizvanov AA, Gulluoglu S, Yalvaç ME, Palotás A, Islamov RR.
    Curr Drug Metab; 2011 Sep 15; 12(7):679-83. PubMed ID: 21740381
    [Abstract] [Full Text] [Related]

  • 7. Rodent Models of Amyotrophic Lateral Sclerosis.
    Philips T, Rothstein JD.
    Curr Protoc Pharmacol; 2015 Jun 01; 69():5.67.1-5.67.21. PubMed ID: 26344214
    [Abstract] [Full Text] [Related]

  • 8. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
    Kaspar BK, Lladó J, Sherkat N, Rothstein JD, Gage FH.
    Science; 2003 Aug 08; 301(5634):839-42. PubMed ID: 12907804
    [Abstract] [Full Text] [Related]

  • 9. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis.
    Alrafiah AR.
    In Vivo; 2018 Aug 08; 32(5):983-998. PubMed ID: 30150420
    [Abstract] [Full Text] [Related]

  • 10. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K, Hala TJ, Seetharam S, Poulsen DJ, Wright MC, Lepore AC.
    Neurobiol Dis; 2015 Jun 08; 78():12-23. PubMed ID: 25818008
    [Abstract] [Full Text] [Related]

  • 11. Recent advances in amyotrophic lateral sclerosis research.
    Przedborski S, Mitsumoto H, Rowland LP.
    Curr Neurol Neurosci Rep; 2003 Jan 08; 3(1):70-7. PubMed ID: 12507415
    [Abstract] [Full Text] [Related]

  • 12. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice.
    Towne C, Raoul C, Schneider BL, Aebischer P.
    Mol Ther; 2008 Jun 08; 16(6):1018-25. PubMed ID: 18414477
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS).
    Abati E, Bresolin N, Comi G, Corti S.
    Expert Opin Ther Targets; 2020 Apr 08; 24(4):295-310. PubMed ID: 32125907
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration.
    Li J, Li T, Zhang X, Tang Y, Yang J, Le W.
    Neurobiol Aging; 2014 Apr 08; 35(4):837-46. PubMed ID: 24126158
    [Abstract] [Full Text] [Related]

  • 18. Has gene therapy for ALS arrived?
    Miller TM, Cleveland DW.
    Nat Med; 2003 Oct 08; 9(10):1256-7. PubMed ID: 14520369
    [No Abstract] [Full Text] [Related]

  • 19. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
    Wang H, Yang B, Qiu L, Yang C, Kramer J, Su Q, Guo Y, Brown RH, Gao G, Xu Z.
    Hum Mol Genet; 2014 Feb 01; 23(3):668-81. PubMed ID: 24108104
    [Abstract] [Full Text] [Related]

  • 20. New therapeutic targets for amyotrophic lateral sclerosis.
    Kuzma-Kozakiewicz M, Kwiecinski H.
    Expert Opin Ther Targets; 2011 Feb 01; 15(2):127-43. PubMed ID: 21133819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.